.png)
.png)
Women in Biotech and Women In Bio team up for our 2nd Transatlantic event!
Joining and Building Diverse Start-up Boards for Success
Thursday 4 November 2021 | 4PM - 7.30PM GMT
Following our fantastic inaugural Transatlantic Women in Biotech event in March, we are working with the fabulous Women In Bio to serve up another incredible opportunity to network, share experience and be inspired by a top selection of speakers and participants from Europe and the States.
This event will focus on Start-Up Board leadership for women – both from the perspectives of women seeking to gain Board experience – and conversely – Start-Ups looking to build a diverse Board. It will therefore be of interest both to seasoned life science leaders looking to expand their experience into Board roles, and to early stage leaders looking for advice on how they can find and attract the Board members they need to help take them to the next stage of development and beyond.
This event will be held online on the Remo platform.
16:00 GMT / 12:00 EST / 09:00 PST Platform opens for networking
16:20 GMT / 12:20 EST / 09:20 PST Welcome
Georgia Attwood, Life Sci Advisors
Lisa Iadicicco, Women in Bio
Jane Wall, BIA
16:30 GMT / 12:30 EST / 09:30 PST Panel: advice for experienced women looking to get onto Start-Up boards
Dimitra Georganopoulou, 3.8 initiative (Chair)
Shahila Christie, Portal Innovations
Angela James, Macrogenics Inc.
Barbara Domayne-Hayman, Francis Crick Institute
Ruth McKernan CBE, Astronautx
17:15 GMT / 13:15 EST / 10:15 PST Networking break
17:30 GMT / 13:30 EST / 10:30 PST Panel: advice for Start-Ups on building diverse boards
Claire Button, Fusion Biomed (Chair)
Anna Lisa Somera, Rhaeos
Caralynn Collens, Dimension Inx
Charlotte Casebourne, Theolytics
18:15 GMT / 14:15 EST / 11:15 PST Networking
19:30 GMT / 15:30 EST / 12:30 PST Close
BIA members* - £23 +VAT (approx. 31 USD + 20% tax**)
Non-members - £35 +VAT (approx. 47 USD + 20% tax**)
*Women in Bio (WIB) members are eligible to receive this same discounted rate, please contact [email protected] for the discount code.
**Tickets for this event are sold in GBP. Cost in US dollars may vary depending on exchange rate at time of purchase.
Please note that American Express cards are not accepted for payment.
Women In Bio was established in 2002 to help women entrepreneurs and executives in the Baltimore-Washington-Northern Virginia area build successful bioscience-related businesses.
The founders of WIB: Cynthia W. Hu, Robbie Melton, Anne Mathias, and Elizabeth Grey wanted to provide a forum for women to come together to celebrate and support each other's success, and in so doing created a dynamic and invaluable forum for the local community.
The mission of WIB expanded several years later, with a vision to grow it to an organization with a national footprint that would impact the careers of women in all sectors of the life sciences industry.
That vision has now become a reality, as we have 13 chapters throughout North America, led by more than 225 volunteers and a membership base of over 2,600. Thousands of women attend WIB events each year, and continue to grow the organization through their ideas, activities and donations.
Thanks to its founders and past presidents, WIB has become a community that represents one of the fastest growing and most influential organizations for women in life sciences.
You will be able to join us online to network and, similar to an in-person event, move from virtual table to table to mingle with other attendees. The platform we will be using also includes useful features which will allow you to message directly with other attendees and share LinkedIn details to connect. There is also a general chat for all attendees.
During the panel discussion you will be able to submit and vote on audience questions and we will try our best to cover everything in the time allocated.
What are the technical requirements to attend the virtual event?
- There is no software installation or download required.
- Please attend using a laptop or desktop computer with audio and video capabilities (webcam and microphone).
- You will need to use one of the supported browsers to have the best user experience: Chrome, Safari, or Firefox.
If your company has firewalls or browsing restrictions in place, please test your connection and liaise with your IT team in advance to ensure you are able to fully participate in the event.
Speakers
Georgia Attwood
Georgia is Managing Director of Business Development at LifeSci Advisors, with a primary focus on client selection and acquisition for European headquartered life Sciences companies, with transatlantic ambitions. Georgia began her career 9 years ago, in corporate development, before spending several years building a strong biotech network as a senior client partner in life sciences board and executive search in the U.K and in Boston. Georgia joined LifeSci Advisors in March 2020.
Claire Button
Dr Claire Button founded Fusion Biomed, a specialist search and investment partner for early stage, high-growth biotech and medtech, to address challenges facing life science and medtech ventures as they grow from interesting technology or science through to exit. After her PhD in Immunopharmacology, Claire spent over 15 years working with entrepreneurs, stakeholders, and boards of ventures like this. She brings deep understanding and a global network; partnering with ventures to build boards, secure investment, find commercial leaders, design business plans and other elements required for company success. Claire is CEO of Mentis Cura, a data-driven neuro-tech platform company, diagnosing brain disorders for early intervention and treatment. She is a member of the medtech committee of Consilience Ventures, an investment fund for early-stage, high-growth ventures. Claire has co-founded life sciences ventures in several fields, including diagnostics, and understands the value of data platforms and AI to healthcare. Claire supports initiatives to encourage and support entrepreneurialism; she presents and mentors on programmes such as KQ Labs at the Francis Crick Institute. She is Advisory Board Member, Mentor and Judge for the GAP Summit, and participates in European and China focused Venture Camps, bringing commercial perspectives to start-up ventures. She is also passionate about empowering women in STEM careers, and actively supports the work of AWiSE.
Charlotte Casebourne
Charlotte believes in equitable access to effective therapies. She is the CEO and Co-founder of Theolytics - a pre-clinical biotech company harnessing viruses to fight cancer - and has been a BIA Board Member since January 2019. This has included audit committee responsibilities, and the ongoing role of Vice Chair of the BIA's Skills, People and Talent Working Party. Previously Co-founder and Director of New Medicine Partners, Charlotte has worked with organisations spanning three continents to support the early translation of novel life science technologies. She has taken leadership roles including Curator of the World Economic Forum Global Shapers network, Managing Director of HealthTech Women London, and HelloTomorrow’s London Chair for Healthcare and Medical Technologies. Charlotte graduated as a University of Cambridge Bioscience Enterprise M.Phil Scholar and was a shortlisted finalist for Cambridge Entrepreneur of the Year. She was most recently named one of Forbes 30 Under 30, and In Vivo’s 30 Rising Leaders in Life Sciences.
Caralynn Collens
Founder, CEO, Board Director, Innovator. Passionate about building teams and organizations that leverage technology to drive transformational change and improve quality of life. Recognized for deploying innovative business models and building strategic partnerships to accelerate new product development. Trusted advisor to corporate executives, entrepreneurs, university leaders, and government on innovation strategy. Track record for translating vision into results that matter and delivering economic returns.
Dr Shahila Christie
Shahila Christie is a scientist entrepreneur with significant R&D experience in the startup space. The initial part of her career focused on preclinical drug discovery and development in the area of infectious diseases with a focus on small molecule therapeutics. She moved onto founding two startups as spinouts from the University, one of which was based directly on her research work.
Barbara Domayne-Hayman
Barbara has worked on the commercial side of life sciences for thirty years, first in a large organisation (ICI/Zeneca/AstraZeneca), before transitioning to the entrepreneurial world of biotech. Barbara joined the Francis Crick Institute in January 2018 as Entrepreneur-in-residence, where amongst other things, she co-founded, led and now is Chair of the KQ Labs accelerator, which is focused on start-ups from all over the UK who are making use of data/AI applied to health. She is also Chief Business Officer of Autifony, where she is responsible for strategic partnering, fundraising and commercial aspects of drug development for CNS disorders. Barbara was also Chair of Puridify, a UCL spin-out with a breakthrough biotherapeutics purification technology, which was acquired by GE (now Cytiva) in November 2017. She is a member of the investment committees of the LifeArc Ventures Fund, and the Cambridge Enterprise Seed Fund. Previously, Barbara was CEO of Stabilitech, and she was Commercial Director at Arrow Therapeutics until the company was acquired by AstraZeneca. Barbara was also Senior Business Development Manager at Celltech. Barbara has a BA and D Phil in Chemistry from the University of Oxford, and is a Sloan Fellow from London Business School.
Dimitra Georganopoulou
Experienced biotech professional with deep knowledge of the MedTech Sector, focused on personalized medicine projects, medical devices, diagnostics, Health IT and therapeutics. A business development leader with extensive licensing expertise, tech due diligence & commercialization training knowledge. Skilled in identifying industry trends with a proven ability to formulate innovation strategy plans.
Lisa Iadicicco
Lisa is the Executive Director for the national non-profit, Women In Bio (WIB), engaging, educating, and empowering all women in the life sciences, from the classroom to the boardroom. She manages the efforts of her staff and over 400 volunteer leaders across North America, to achieve our mission to move the needle on diversity and inclusion within the life sciences and beyond. She is a leadership expert who delivers with high-energy, the goals of the organization. Challenging WIB members and supporters to leverage their focus and pay attention to what matters most…equity and inclusion. Lisa earned her BS from Purdue University and her Certification from the Center For Women’s Entrepreneurship from Chatham University. She has received numerous awards for her efforts in both academia and industry. Her strong background in entrepreneurship, business development, and managing multifunctional teams, makes her the perfect fit to head up WIB’s efforts. Lisa, before joining WIB, was a Senior Management Consultant for the Innovation Institute at the University of Pittsburgh, where she guided start-ups and scaling businesses to achieve their highest potential.
Dr Angela James
Dr. Angela James is the Vice-Chair of Women In Bio Chicago and Vice President, Head of Clinical Pharmacology, at MacroGenics Inc. With 20 years of experience in drug development, she is passionate about utilizing her scientific acumen and leadership abilities to bring novel therapeutics to patients who urgently need safe and effective drugs. Equally important is her role as a mentor for early career scientists and students of all ages. Dr. James sits on the Board of Directors for Youth Technology Corps and the Board of Advisors for the MIT Catalyst program.
Dr Ruth McKernan
Dr Ruth McKernan CBE joined Innovate UK as Chief Executive in May 2015. Ruth has 25 years of research and commercial experience in the pharmaceutical industry, including heading up research units in the UK and the US. She is a member of the Science, Industry and Translation Committee of the Royal Society and was a Council Member for the Medical Research Council for 5 years. Ruth’s previous roles include Senior Vice President at Pfizer and Head of the Merck Neuroscience Research Centre. Ruth’s awards and achievements include a CBE in 2013 for services to Business, Innovation and Skills, a Fulbright Scholarship and a Glaxo/ABSW Science Writers’ Award. Ruth is the author of a book for non-scientists, “Billy’s Halo”.
Anna Lisa Somera
Anna Lisa is an experienced life science start up consultant, venture capitalist, intellectual property analyst, technology transfer specialist, biomedical researcher, and entrepreneur specialized in early-stage, cutting edge technology businesses. She has been a part of the entrepreneurial community for 17 years. She helped drive the formation and raised angel and venture funding for several start-up companies while also serving as top management for many of the ventures. She also led regulatory affairs, quality, and operations for several medical device companies. She also has extensive experience in non-dilutive funding having helped new technology ventures receive over $40M in SBIR/STTR, state and private grants.
Jane Wall
What does your role at BIA involve?
Strategic leadership of the organisation and oversight of P&L to ensure that BIA is a sustainable, successful, and ever-evolving association. Serving the needs of existing members, growing new communities, and increasing member benefit; producing sector-leading thought leadership and events, growing influence, reach and impact.
Previous experience & achievements
25 years of experience managing teams in academic publishing and membership organisations: providing strategic and editorial direction combined with business acumen; driving operational, organisational and community development, profitability, and innovation. Previous roles at Oxford University Press, Taylor & Francis (Informa PLC), Oxford Brookes University, Fire Protection Association and Food and Drink Federation. Jane holds a first degree in Italian and European Literature from Warwick University, MA in Social Anthropology from SOAS and MBA from Oxford Brookes Business School.
If you could invite any scientist to dinner, who would it be?
Galileo Galilei: having been slightly obsessed with Italian culture and the Renaissance, I was fascinated by Florence, the Medicis and their patronage of artists and scientists. I am always in awe of the bravery and foresight of individuals willing to push human understanding beyond what was/is generally acceptable at the time: Galileo was willing to risk the ire of the Inquisition and to live condemned as a heretic in times when the punishment was extreme – to become the ‘father of modern science’.
Thank you to our event partners
Thank you to our event supporters
